sucralfate
Drug Details
- Generic Name
- sucralfate
- Brand Names
- sucralfate, Sucralfate oral suspension
- Application Number
- ANDA212913
- Sponsor
- Mylan Pharmaceuticals Inc.
- NDC Codes
- 3
- Dosage Forms
- SUSPENSION, TABLET
- Routes
- ORAL
- Active Ingredients
- SUCRALFATE
Indications and Usage
INDICATIONS AND USAGE Sucralfate tablets, USP are indicated in: Short-term treatment (up to 8 weeks) of active duodenal ulcer. While healing with sucralfate may occur during the first week or two, treatment should be continued for 4 to 8 weeks unless healing has been demonstrated by x-ray or endoscopic examination. Maintenance therapy for duodenal ulcer patients at reduced dosage after healing of acute ulcers.